Keros Therapeutics (KROS) EPS (Basic) (QoQ) (2019 - 2025)
Powered by 
Analysis
Keros Therapeutics (KROS) EPS (Basic) (QoQ) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.67 Bn | 192.69 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.06 Bn | 176.88 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.44 Bn | 123.59 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.95 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn |
| 6 | Moderna | 53.87 Bn | 48.73 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.15 Bn | 29.85 Bn | 992.69 Mn |
| 8 | Biogen | 31.88 Bn | 30.60 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.16 Bn | 29.16 Bn | 1.16 Mn |
| 10 | Keros Therapeutics | 219.59 Mn | -38.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -251.72% |
| Sep 30, 2025 | 76.29% |
| Jun 30, 2025 | -120.65% |
| Mar 31, 2025 | 397.71% |
| Dec 31, 2024 | 12.73% |
| Sep 30, 2024 | -12.38% |
| Jun 30, 2024 | -3.76% |
| Mar 31, 2024 | 11.59% |
| Dec 31, 2023 | -2.80% |
| Sep 30, 2023 | -4.93% |
| Jun 30, 2023 | -0.39% |
| Mar 31, 2023 | -7.19% |
| Dec 31, 2022 | -27.96% |
| Sep 30, 2022 | 18.83% |
| Jun 30, 2022 | -12.45% |
| Mar 31, 2022 | -238.92% |
| Dec 31, 2021 | 65.77% |
| Sep 30, 2021 | -29.61% |
| Jun 30, 2021 | 1.98% |
| Mar 31, 2021 | -9.72% |